97 related articles for article (PubMed ID: 18063753)
1. Hls5 regulated erythroid differentiation by modulating GATA-1 activity.
Endersby R; Majewski IJ; Winteringham L; Beaumont JG; Samuels A; Scaife R; Lim E; Crossley M; Klinken SP; Lalonde JP
Blood; 2008 Feb; 111(4):1946-50. PubMed ID: 18063753
[TBL] [Abstract][Full Text] [Related]
2. HLS7, a hemopoietic lineage switch gene homologous to the leukemia-inducing gene MLF1.
Williams JH; Daly LN; Ingley E; Beaumont JG; Tilbrook PA; Lalonde JP; Stillitano JP; Klinken SP
EMBO J; 1999 Oct; 18(20):5559-66. PubMed ID: 10523300
[TBL] [Abstract][Full Text] [Related]
3. HLS5, a novel RBCC (ring finger, B box, coiled-coil) family member isolated from a hemopoietic lineage switch, is a candidate tumor suppressor.
Lalonde JP; Lim R; Ingley E; Tilbrook PA; Thompson MJ; McCulloch R; Beaumont JG; Wicking C; Eyre HJ; Sutherland GR; Howe K; Solomon E; Williams JH; Klinken SP
J Biol Chem; 2004 Feb; 279(9):8181-9. PubMed ID: 14662771
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry.
Grosveld F; Rodriguez P; Meier N; Krpic S; Pourfarzad F; Papadopoulos P; Kolodziej K; Patrinos GP; Hostert A; Strouboulis J
Ann N Y Acad Sci; 2005; 1054():55-67. PubMed ID: 16339652
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.
Buck I; Morceau F; Cristofanon S; Heintz C; Chateauvieux S; Reuter S; Dicato M; Diederich M
Biochem Pharmacol; 2008 Nov; 76(10):1229-39. PubMed ID: 18805401
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
Chang TJ; Scher BM; Waxman S; Scher W
Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
[TBL] [Abstract][Full Text] [Related]
7. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression.
Gregory T; Yu C; Ma A; Orkin SH; Blobel GA; Weiss MJ
Blood; 1999 Jul; 94(1):87-96. PubMed ID: 10381501
[TBL] [Abstract][Full Text] [Related]
8. Differential context-dependent effects of friend of GATA-1 (FOG-1) on mast-cell development and differentiation.
Sugiyama D; Tanaka M; Kitajima K; Zheng J; Yen H; Murotani T; Yamatodani A; Nakano T
Blood; 2008 Feb; 111(4):1924-32. PubMed ID: 18063754
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
[TBL] [Abstract][Full Text] [Related]
10. Transactivation of erythroid transcription factor GATA-1 by a myb-ets-containing retrovirus.
Aurigemma RE; Blair DG; Ruscetti SK
J Virol; 1992 May; 66(5):3056-61. PubMed ID: 1560536
[TBL] [Abstract][Full Text] [Related]
11. FOG-1 and GATA-1 act sequentially to specify definitive megakaryocytic and erythroid progenitors.
Mancini E; Sanjuan-Pla A; Luciani L; Moore S; Grover A; Zay A; Rasmussen KD; Luc S; Bilbao D; O'Carroll D; Jacobsen SE; Nerlov C
EMBO J; 2012 Jan; 31(2):351-65. PubMed ID: 22068055
[TBL] [Abstract][Full Text] [Related]
12. Evidence for distinct regulation processes in the aclacinomycin- and doxorubicin-mediated differentiation of human erythroleukemic cells.
Morceau F; Aries A; Lahlil R; Devy L; Jardillier JC; Jeannesson P; Trentesaux C
Biochem Pharmacol; 1996 Mar; 51(6):839-45. PubMed ID: 8602880
[TBL] [Abstract][Full Text] [Related]
13. The level of the tissue-specific factor GATA-1 affects the cell-cycle machinery.
Whyatt DJ; Karis A; Harkes IC; Verkerk A; Gillemans N; Elefanty AG; Vairo G; Ploemacher R; Grosveld F; Philipsen S
Genes Funct; 1997 Feb; 1(1):11-24. PubMed ID: 9680325
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-3 and erythropoietin cooperate in the regulation of the expression of erythroid-specific transcription factors during erythroid differentiation.
Ghinassi B; Verrucci M; Jelicic K; Di Noia A; Migliaccio G; Migliaccio AR
Exp Hematol; 2007 May; 35(5):735-47. PubMed ID: 17577923
[TBL] [Abstract][Full Text] [Related]
15. Smad2/3-pathway ligand trap luspatercept enhances erythroid differentiation in murine β-thalassaemia by increasing GATA-1 availability.
Martinez PA; Li R; Ramanathan HN; Bhasin M; Pearsall RS; Kumar R; Suragani RNVS
J Cell Mol Med; 2020 Jun; 24(11):6162-6177. PubMed ID: 32351032
[TBL] [Abstract][Full Text] [Related]
16. Hemoglobin switching in humans is accompanied by changes in the ratio of the transcription factors, GATA-1 and SP1.
Bacon ER; Dalyot N; Filon D; Schreiber L; Rachmilewitz EA; Oppenheim A
Mol Med; 1995 Mar; 1(3):297-305. PubMed ID: 8529108
[TBL] [Abstract][Full Text] [Related]
17. The inhibitory effect of the proinflammatory cytokine TNFalpha on erythroid differentiation involves erythroid transcription factor modulation.
Buck I; Morceau F; Cristofanon S; Reuter S; Dicato M; Diederich M
Int J Oncol; 2009 Mar; 34(3):853-60. PubMed ID: 19212691
[TBL] [Abstract][Full Text] [Related]
18. Repression of c-kit and its downstream substrates by GATA-1 inhibits cell proliferation during erythroid maturation.
Munugalavadla V; Dore LC; Tan BL; Hong L; Vishnu M; Weiss MJ; Kapur R
Mol Cell Biol; 2005 Aug; 25(15):6747-59. PubMed ID: 16024808
[TBL] [Abstract][Full Text] [Related]
19. Dependence for the proliferative response to erythropoietin on an established erythroid differentiation program in a human hematopoietic cell line, UT-7.
Nicolis S; Ottolenghi S; Papayannopoulou T; Baiocchi M; Migliaccio G; Adamson J; Migliaccio AR
Exp Hematol; 1993 May; 21(5):665-70. PubMed ID: 8513868
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase/Akt induced by erythropoietin renders the erythroid differentiation factor GATA-1 competent for TIMP-1 gene transactivation.
Kadri Z; Maouche-Chretien L; Rooke HM; Orkin SH; Romeo PH; Mayeux P; Leboulch P; Chretien S
Mol Cell Biol; 2005 Sep; 25(17):7412-22. PubMed ID: 16107690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
